Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riviciclib in Relapsed/Refractory Mantle Cell Lymphoma
NCT00843050Phase 2Terminated
- Sponsor
- Piramal Enterprises Limited
- Start
- Nov 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of P276 in mantle cell lymphoma (MCL), sponsored by Piramal Enterprises Limited. Started Nov 2009; status: terminated.
02
Drugs
P276
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00843050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843050.